SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 29, 2021 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Dec. 29, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial...
SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance
November 10, 2021 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Nov. 10, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today reported financial results for the third quarter ended September 30, 2021. Recent...
SOPHiA GENETICS to Participate in Upcoming November Investor Conferences
October 28, 2021 16:05 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Oct. 28, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced the company will be participating virtually in the following investor...
SOPHiA GENETICS to Report Third Quarter 2021 Financial Results on November 10, 2021
October 27, 2021 16:05 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Oct. 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the third quarter of 2021 before market...
SOPHiA GENETICS Reports Second Quarter 2021 Financial Results and Issues 2021 Guidance
September 09, 2021 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ: SOPH), today reported financial results for the three months ended June 30, 2021. Recent...
SOPHiA GENETICS to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
August 30, 2021 16:05 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Aug. 30, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today announced the company will be participating in the Morgan Stanley 19th Annual Global...
UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021
August 26, 2021 12:43 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market...
SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021
August 26, 2021 09:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market...
SOPHiA GENETICS Announces Closing of $234 Million Initial Public Offering and $20 Million Private Placement
July 27, 2021 16:05 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, July 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven...
SOPHiA GENETICS Announces Pricing of Initial Public Offering
July 22, 2021 18:05 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, July 22, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine,...